Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Clinical implications of GRHL3 protein expression in breast cancer.

Xu H, Liu C, Zhao Z, Gao N, Chen G, Wang Y, Cui J.

Tumour Biol. 2014 Mar;35(3):1827-31. doi: 10.1007/s13277-013-1244-7. Epub 2013 Dec 22.

PMID:
24363083
2.

Nestin: predicting specific survival factors for breast cancer.

Gao N, Xu H, Liu C, Xu H, Chen G, Wang X, Li Y, Wang Y.

Tumour Biol. 2014 Mar;35(3):1751-5. doi: 10.1007/s13277-013-1548-7. Epub 2014 Jan 18.

PMID:
24443256
3.

Clinical implications of β-catenin protein expression in breast cancer.

Wang Z, Zhang H, Hou J, Niu J, Ma Z, Zhao H, Liu C.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):14989-94. eCollection 2015.

4.

Clinicopathological significance of ARID1B in breast invasive ductal carcinoma.

Shao F, Guo T, Chua PJ, Tang L, Thike AA, Tan PH, Bay BH, Baeg GH.

Histopathology. 2015 Nov;67(5):709-18. doi: 10.1111/his.12701. Epub 2015 May 17.

PMID:
25817822
5.

Prognostic significance of HOXD13 expression in human breast cancer.

Zhong ZB, Shan M, Qian C, Liu T, Shi QY, Wang J, Liu Y, Liu Y, Huang YX, Pang D.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):11407-13. eCollection 2015.

6.

Clinicopathological significance and prognostic value of Xeroderma pigmentosum complementary group C (XPC) expression in sporadic breast cancer patients.

Bai X, Jin F, Fu Y, Yu Z, Zhao L, Ren J, Li Y, Jiao X, Zhao H, Yao W, Mi X, Wang E, Olopade OI, Zhou M, Wei M.

Med Oncol. 2012 Sep;29(3):1543-53. doi: 10.1007/s12032-011-0086-7. Epub 2011 Oct 30.

PMID:
22038723
7.

Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression.

Alford SH, Toy K, Merajver SD, Kleer CG.

Breast Cancer Res Treat. 2012 Apr;132(2):429-37. doi: 10.1007/s10549-011-1591-2. Epub 2011 May 26.

8.

Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.

De Brot M, Rocha RM, Soares FA, Gobbi H.

Pathology. 2012 Jun;44(4):303-12. doi: 10.1097/PAT.0b013e3283534bcb.

PMID:
22544210
9.

Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.

Heimes AS, Madjar K, Edlund K, Battista MJ, Almstedt K, Gebhard S, Foersch S, Rahnenführer J, Brenner W, Hasenburg A, Hengstler JG, Schmidt M.

J Cancer Res Clin Oncol. 2017 Jul;143(7):1123-1131. doi: 10.1007/s00432-017-2377-7. Epub 2017 Mar 1.

PMID:
28251349
10.

Quantitative immunohistochemical analysis and prognostic significance of TRPS-1, a new GATA transcription factor family member, in breast cancer.

Chen JQ, Litton J, Xiao L, Zhang HZ, Warneke CL, Wu Y, Shen X, Wu S, Sahin A, Katz R, Bondy M, Hortobagyi G, Berinstein NL, Murray JL, Radvanyi L.

Horm Cancer. 2010 Feb;1(1):21-33. doi: 10.1007/s12672-010-0008-8. Epub 2010 Feb 13.

PMID:
21761348
11.

Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.

Cao YW, Li WQ, Wan GX, Li YX, Du XM, Li YC, Li F.

J Exp Clin Cancer Res. 2014 Nov 25;33:97. doi: 10.1186/s13046-014-0097-2.

12.

Expression of ALDH1 and TGFβ2 in benign and malignant breast tumors and their prognostic implications.

Zheng R, Wang J, Wu Q, Wang Z, Ou Y, Ma L, Wang M, Wang J, Yang Y.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):4173-83. eCollection 2014.

13.

Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China.

Deng Q, Yang H, Lin Y, Qiu Y, Gu X, He P, Zhao M, Wang H, Xu Y, Lin Y, Jiang J, He J, Zhou JX.

Int J Clin Exp Pathol. 2014 Dec 1;7(12):8312-21. eCollection 2014. Review.

14.

Girdin protein: a new potential distant metastasis predictor of breast cancer.

Liu C, Zhang Y, Xu H, Zhang R, Li H, Lu P, Jin F.

Med Oncol. 2012 Sep;29(3):1554-60. doi: 10.1007/s12032-011-0087-6. Epub 2011 Nov 25.

PMID:
22116776
15.

Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome.

Shubbar E, Kovács A, Hajizadeh S, Parris TZ, Nemes S, Gunnarsdóttir K, Einbeigi Z, Karlsson P, Helou K.

BMC Cancer. 2013 Jan 2;13:1. doi: 10.1186/1471-2407-13-1.

16.

High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer.

Zhao H, Yang M, Zhao J, Wang J, Zhang Y, Zhang Q.

Med Oncol. 2013 Mar;30(1):475. doi: 10.1007/s12032-013-0475-1. Epub 2013 Feb 1.

PMID:
23371253
17.

Histone demethylase GASC1--a potential prognostic and predictive marker in invasive breast cancer.

Berdel B, Nieminen K, Soini Y, Tengström M, Malinen M, Kosma VM, Palvimo JJ, Mannermaa A.

BMC Cancer. 2012 Nov 14;12:516. doi: 10.1186/1471-2407-12-516.

18.

Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma.

Zhao P, Lu Y, Jiang X, Li X.

Cancer Sci. 2011 May;102(5):1107-11. doi: 10.1111/j.1349-7006.2011.01894.x. Epub 2011 Feb 28.

19.

LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer.

Li N, Zheng Y, Xuan C, Lin Z, Piao L, Liu S.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):12893-900. eCollection 2015.

20.

The role of pleomorphic adenoma gene-like 2 in gastrointestinal cancer development, progression, and prognosis.

Liu B, Lu C, Song YX, Gao P, Sun JX, Chen XW, Wang MX, Dong YL, Xu HM, Wang ZN.

Int J Clin Exp Pathol. 2014 May 15;7(6):3089-100. eCollection 2014.

Supplemental Content

Support Center